3Q4B

Clinically Useful Alkyl Amine Renin Inhibitors


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.19 Å
  • R-Value Free: 0.263 
  • R-Value Work: 0.209 
  • R-Value Observed: 0.212 

wwPDB Validation   3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility.

Jia, L.Simpson, R.D.Yuan, J.Xu, Z.Zhao, W.Cacatian, S.Tice, C.M.Guo, J.Ishchenko, A.Singh, S.B.Wu, Z.McKeever, B.M.Bukhtiyarov, Y.Johnson, J.A.Doe, C.P.Harrison, R.K.McGeehan, G.M.Dillard, L.W.Baldwin, J.J.Claremon, D.A.

(2011) ACS Med Chem Lett 2: 747-751

  • DOI: 10.1021/ml200137x
  • Primary Citation of Related Structures:  
    3Q4B, 3Q5H

  • PubMed Abstract: 
  • Structure guided optimization of a series of nonpeptidic alkyl amine renin inhibitors allowed the rational incorporation of additional polar functionality. Replacement of the cyclohexylmethyl group occupying the S1 pocket with a (R)-(tetrahydropyran- ...

    Structure guided optimization of a series of nonpeptidic alkyl amine renin inhibitors allowed the rational incorporation of additional polar functionality. Replacement of the cyclohexylmethyl group occupying the S1 pocket with a (R)-(tetrahydropyran-3-yl)methyl group and utilization of a different attachment point led to the identification of clinical candidate 9. This compound demonstrated excellent selectivity over related and unrelated off-targets, >15% oral bioavailability in three species, oral efficacy in a double transgenic rat model of hypertension, and good exposure in humans.


    Organizational Affiliation

    Vitae Pharmaceuticals, 502 West Office Center Drive, Fort Washington, Pennsylvania 19034, United States.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
ReninAB340Homo sapiensMutation(s): 0 
Gene Names: RENrenin
EC: 3.4.23.15
Find proteins for P00797 (Homo sapiens)
Explore P00797 
Go to UniProtKB:  P00797
NIH Common Fund Data Resources
PHAROS  P00797
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 3 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
RX5
Query on RX5

Download CCD File 
A, B
methyl (2-{(R)-(3-chlorophenyl)[(3R)-1-({(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl}carbamoyl)piperidin-3-yl] methoxy}ethyl)carbamate
C26 H41 Cl N4 O5
NXWASIVXQMMPLM-ZXMXYHOLSA-N
 Ligand Interaction
NAG
Query on NAG

Download CCD File 
A
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
 Ligand Interaction
CL
Query on CL

Download CCD File 
A, B
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
RX5IC50:  0.4699999988079071   nM  BindingDB
RX5IC50:  0.5   nM  BindingDB
RX5IC50:  0.30000001192092896   nM  BindingDB
RX5IC50 :  0.4699999988079071   nM  PDBBind
RX5IC50:  1.100000023841858   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.19 Å
  • R-Value Free: 0.263 
  • R-Value Work: 0.209 
  • R-Value Observed: 0.212 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 54.43α = 90
b = 98.058β = 90
c = 148.844γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
CNSrefinement
CBASSdata collection
HKL-2000data reduction
HKL-2000data scaling
CNSphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2010-12-23 
  • Released Date: 2011-11-30 
  • Deposition Author(s): Wu, Z., McKeever, B.M.

Revision History 

  • Version 1.0: 2011-11-30
    Type: Initial release
  • Version 1.1: 2014-09-24
    Changes: Database references
  • Version 1.2: 2019-07-17
    Changes: Data collection, Derived calculations, Refinement description
  • Version 1.3: 2020-07-29
    Type: Remediation
    Reason: Carbohydrate remediation
    Changes: Data collection, Derived calculations, Structure summary